| APA |
Acar, M., Tatlı, S., & Silverman, S. G. (2013). Leiomyomatosis Peritonealis Disseminata: MRI Features Before and After Treatment with GnRH Agonist. European Journal of General Medicine, 10(4). https://izlik.org/JA67YR43ER
|
|
| AMA |
1.Acar M, Tatlı S, Silverman SG. Leiomyomatosis Peritonealis Disseminata: MRI Features Before and After Treatment with GnRH Agonist. European Journal of General Medicine. 2013;10(4). https://izlik.org/JA67YR43ER
|
|
| Chicago |
Acar, Murat, Servet Tatlı, and Stuart G Silverman. 2013. “Leiomyomatosis Peritonealis Disseminata: MRI Features Before and After Treatment With GnRH Agonist”. European Journal of General Medicine 10 (4). https://izlik.org/JA67YR43ER.
|
|
| EndNote |
Acar M, Tatlı S, Silverman SG (December 1, 2013) Leiomyomatosis Peritonealis Disseminata: MRI Features Before and After Treatment with GnRH Agonist. European Journal of General Medicine 10 4
|
|
| IEEE |
[1]M. Acar, S. Tatlı, and S. G. Silverman, “Leiomyomatosis Peritonealis Disseminata: MRI Features Before and After Treatment with GnRH Agonist”, European Journal of General Medicine, vol. 10, no. 4, Dec. 2013, [Online]. Available: https://izlik.org/JA67YR43ER
|
|
| ISNAD |
Acar, Murat - Tatlı, Servet - Silverman, Stuart G. “Leiomyomatosis Peritonealis Disseminata: MRI Features Before and After Treatment With GnRH Agonist”. European Journal of General Medicine 10/4 (December 1, 2013). https://izlik.org/JA67YR43ER.
|
|
| JAMA |
1.Acar M, Tatlı S, Silverman SG. Leiomyomatosis Peritonealis Disseminata: MRI Features Before and After Treatment with GnRH Agonist. European Journal of General Medicine. 2013;10. Available at https://izlik.org/JA67YR43ER.
|
|
| MLA |
Acar, Murat, et al. “Leiomyomatosis Peritonealis Disseminata: MRI Features Before and After Treatment With GnRH Agonist”. European Journal of General Medicine, vol. 10, no. 4, Dec. 2013, https://izlik.org/JA67YR43ER.
|
|
| Vancouver |
1.Murat Acar, Servet Tatlı, Stuart G Silverman. Leiomyomatosis Peritonealis Disseminata: MRI Features Before and After Treatment with GnRH Agonist. European Journal of General Medicine [Internet]. 2013 Dec. 1;10(4). Available from: https://izlik.org/JA67YR43ER
|
|